Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice

Documenti analoghi

• Bone mineral density in patients with rheumatoid arthritis treated with infliximab
  di: Vis, M, et al.
  Pubblicazione: (2005)
• Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis
  di: Wolbink, G, et al.
  Pubblicazione: (2005)
• Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis
  di: Peters, M J L, et al.
  Pubblicazione: (2007)
• Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
  di: van der Maas, Aatke, et al.
  Pubblicazione: (2012)
• Infliximab treatment reduces complement activation in patients with rheumatoid arthritis
  di: Familian, A, et al.
  Pubblicazione: (2005)